ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,572Hybrid

Drug Safety

Acronym:drsa
•
Abbreviation (ISO):DRUG SAFETY
•
Identifier (ISSN):0114-5916(Print)/1179-1942(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
5.9↑ +2.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Safety

WoS Q1
24683.5820183.5320193.4420205.6120215.2320224.22023420243.820255.92026
Annual Impact Factor Metric
Current (2026):5.9
Scopus SJR & RankScopus Q1
1.452
#2,572

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
151

151 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate7.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
83articles/year
60.93% Gold OA•76.64% Original Research

Aims & Scope

Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

Topics Covered (Recognized by AI)
MedicineBiology90.1%Internal medicine81.7%Pharmacology73.9%Psychology61.1%Psychiatry57.7%Adverse effect47.5%Pathology44.4%Drug39.9%Chemistry37.3%Biochemistry33%Genetics30.5%Intensive care medicine27.5%Surgery26.2%Mathematics25.9%Endocrinology23.4%Statistics22%Political science21%Law20.9%Computer science20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank49/356
IndexSCIE
JCRSCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q1
Rank34/443
IndexSCIE
JCRSCIE2026

TOXICOLOGY

Q1
Rank12/106
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank43/356
IndexSCIE
JCISCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q1
Rank46/443
IndexSCIE
JCISCIE2026

TOXICOLOGY

Q1
Rank11/106
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.9
Articles / Year66
Total Citations31
2025
IF3.8
Articles / Year133
Total Citations400
2024
IF4
Articles / Year117
Total Citations1,533
2023
IF4.2
Articles / Year121
Total Citations1,521
2022
IF5.228
Articles / Year129
Total Citations2,453

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,572Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.452

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.25

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,459 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,645
3-Year Documents324
Citable Documents288

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate51.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1
Pharmacology (medical)Q1
ToxicologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Safety (acronym: drsa, abbr: DRUG SAFETY, ISSN: 0114-5916) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 1986. The periodical holds a Journal Impact Factor (JIF) of 5.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.452 (Q1), an H-index of 151.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 83 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,459 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Monthly
Founding Year
1986
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a71cb404-acef-4792-91ca-d5173d5aa09f
Database Updated: 2026-10-01